Skip to main content

XWELL Inc

For the period ended Dec 31, 2023. Filed Apr 16, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 16, 2024

XWEL$0.54-4.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Operations and Comprehensive Loss

(In thousands, except share and per share data)

​​​​​​​
​ · ​ · Year ended December 31,
​20232022
​​​​​​​
Revenue, net · ​ · ​
Patient services revenue​$250​$32,776
Services​​27,053​​21,227
Products​2,766​1,930
Other​​40​​6
Total revenue, net​30,109​55,939
​​​​​​​
Cost of sales​​
Labor​17,932​21,437
Occupancy​4,473​4,138
Products and other operating costs​4,023​18,316
Total cost of sales​26,428​43,891
​​​​​​​
Gross Profit​​3,681​​12,048
​​​​​​​
Depreciation and amortization​2,065​5,429
Impairment of long-lived assets​​3,927​​4,669
Goodwill impairment​​4,024​​-
Loss on disposal of assets, net​​34​​834
Impairment of operating lease right-of-use assets​​926​​1,110
General and administrative​12,957​21,178
Salaries and benefits​​7,954​​9,991
Total operating expenses​31,887​43,211
Operating loss​(28,206)​(31,163)
Interest income, net​448​384
Foreign exchange loss​​(738)​​(664)
Gain on securities, realized and unrealized​​912​​—
Other non-operating expense, net​(410)​(1,131)
Loss before income taxes​(27,994)​(32,574)
Income tax expense​(35)​(55)
Net loss​​(28,029)​​(32,629)
Net (income) loss attributable to noncontrolling interests​288​(208)
Net loss attributable to XWELL, Inc.​$(27,741)​$(32,837)
​​​​​​​
Net loss​​(28,029)​​(32,629)
Foreign currency translation​(1,390)​(222)
Comprehensive loss​$(29,419)​$(32,851)
Loss per share​​
Basic and diluted loss per share​$(6.64)​$(7.01)
Weighted-average number of shares outstanding during the period*​​
Basic​4,175,220​4,682,767
Diluted​4,175,220​4,682,767
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.